Epstein-Barr virus associated disease following blood or marrow transplant

Pediatr Transplant. 2003:7 Suppl 3:44-50. doi: 10.1034/j.1399-3046.7.s3.6.x.

Abstract

EBV associated disease continues to be a problem in the post-BHT population. The pathogenesis, risk factors, and diagnosis of PTLD, as well as the rationale, efficacy and advantages/disadvantages of various prophylactic, pre-emptive and treatment strategies are discussed.

Publication types

  • Review

MeSH terms

  • Blood Transfusion*
  • Bone Marrow Transplantation / immunology*
  • Epstein-Barr Virus Infections / immunology*
  • Humans
  • Immunosuppression Therapy
  • Immunotherapy, Adoptive
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / therapy
  • Lymphoproliferative Disorders / virology*
  • Risk Factors